However, in isolated mouse hearts perfused with the sAC inhibitor KH7, we observed loss of cardioprotection with GLP-1(2836), but not GLP-1, as measured by LVDP at the end of the reperfusion (25.2 1.7 mmHg, n = 3, vs
No clear causal link exists between tirzepatide and depression based on current evidence, but the FDA continues to collect safety data
CV primary is a composite of cardiovascular death, non-fatal MI, non-fatal stroke, and heart-failure events
Some medicines may not be safe for patients with thyroid cancer history, pancreatitis, gallbladder disease, digestive problems, pregnancy plans, or medication interactions
Savings: $1,200-$1,800 over 12 months Switch to tirzepatide only if weight loss plateaus after 3-4 months on semaglutide